Kimura Niko, Maeki Masatoshi, Sato Yusuke, Note Yusuke, Ishida Akihiko, Tani Hirofumi, Harashima Hideyoshi, Tokeshi Manabu
Graduate School of Chemical Sciences and Engineering, Hokkaido University, Kita 13 Nishi 8, Kita-ku, Sapporo 060-8628, Japan.
Division of Applied Chemistry, Faculty of Engineering, Hokkaido University, Kita 13 Nishi 8, Kita-ku, Sapporo 060-8628, Japan.
ACS Omega. 2018 May 9;3(5):5044-5051. doi: 10.1021/acsomega.8b00341. eCollection 2018 May 31.
The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications.
基于脂质纳米颗粒(LNP)的纳米药物递送系统(DDS)载体的精确尺寸控制,例如将LNP的尺寸调节至10nm,是下一代纳米药物开发面临的一大挑战。尺寸可控的LNP能够实现尺寸选择性肿瘤靶向,并通过穿过基质细胞将DNA和RNA有效递送至靶向肿瘤组织。在此,我们开发了一种名为侵入式脂质纳米颗粒生产装置(简称iLiNP装置)的挡板混合器装置,其具有简单的二维微通道和混合器结构,并且我们首次实现了在20至100nm尺寸范围内以10nm间隔对LNP尺寸进行调节。与传统的LNP制备方法和已报道的微混合器装置相比,我们的iLiNP装置展现出了更好的LNP尺寸可控性、装置设计的稳健性以及LNP生产率。此外,我们使用iLiNP装置制备了包封有小干扰RNA(siRNA)的80nm大小的LNP;在一项实验中,这些LNP作为纳米DDS载体有效地发挥了作用。我们期望iLiNP装置将成为纳米DDS应用中LNP生产的新型设备。